DNA adducts and combinations of multiple lung cancer at-risk alleles in environmentally exposed and smoking subjects

Environmental and Molecular Mutagenesis

Volumn 54, Issue 6, 2013, Pages 375-383

  Peluso, Marco E M ^a   Munnia, Armelle ^a   Srivatanakul, Petcharin ^b   Jedpiyawongse, Adisorn ^b   Sangrajrang, Suleeporn ^b   Ceppi, Marcello ^c   Godschalk, Roger W L ^d   van Schooten, Frederik J ^d   Boffetta, Paolo ^e,f  

^a Cancer Prevention and Research Institute   (Italy)

^b NATIONAL CANCER INSTITUTE   (Thailand)

^c UNIVERSITY OF GENOA   (Italy)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

DNA adducts; Environmental exposures; Genetic susceptibility; Multiple alleles

Indexed keywords

ACYLTRANSFERASE; CARCINOGEN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; EPOXIDE HYDROLASE; MANGANESE SUPEROXIDE DISMUTASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; ALLELE; ARTICLE; DNA ADDUCT; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC DAMAGE; HOMEOSTASIS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SMOKING;

DNA ADDUCTS; ENVIRONMENTAL EXPOSURES; GENETIC SUSCEPTIBILITY; MULTIPLE ALLELES;

DNA ADDUCTS; DNA DAMAGE; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ENVIRONMENTAL EXPOSURE; EPOXIDE HYDROLASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LUNG NEOPLASMS; NAD(P)H DEHYDROGENASE (QUINONE); RISK; SMOKING; SUPEROXIDE DISMUTASE; TOBACCO SMOKE POLLUTION;

EID: 84880043704     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21788     Document Type: Article

References (54)

1. Agudo A, Peluso M, Sala N, Capellá G, Munnia A, Piro S, Marín F, Ibáñez R, Amiano P, Tormo MJ, Ardanaz E, Barricarte A, Chirlaque MD, Dorronsoro M, Larrañaga N, Martínez C, Navarro C, Quirós JR, Sánchez MJ, González CA. 2009. Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: Findings from the EPIC-Spain cohort. Carcinogenesis 30:968-976.
2. Agudo A, Peluso M, Munnia A, Luján-Barroso L, Sánchez MJ, Molina-Montes E, Sánchez-Cantalejo E, Navarro C, Tormo MJ, Chirlaque MD, Barricarte A, Ardanaz E, Amiano P, Dorronsoro M, Quirós JR, Piro S, Bonet C, Sala N, González CA. 2012. Aromatic DNA adducts and risk of gastrointestinal cancers: A case-cohort study within the EPIC-Spain. Cancer Epidemiol Biomarkers Prev 21:685-692.
3. Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, Manzi L, Veglia F, Autrup H, Dunning A, Garte S, Hainaut P, Hoek G, Krzyzanowski M, Malaveille C, Matullo G, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Peluso M, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Chirlaque MD, Quiros JR, Berglund G, Järvholm B, Hallmans G, Day NE, Allen N, Saracci R, Kaaks R, Riboli E. 2005. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiol Biomarkers Prev 14:2118-21124.
4. Amos CI, Xu W, Spitz MR. 1999. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res 151:3-12.
5. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS. 2008. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40:616-622.
6. Balu N, Padgett WT, Nelson GB, Lambert GR, Ross JA, Nesnow S. 2006. Benzo[a]pyrene-7, 8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: Detection of benzo[a]pyrene-7, 8-quinone-calf thymus DNA adducts. Anal Biochem 55:213-223.
7. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. 2008. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: A literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759-774.
8. Chen B, Qiu LX, Li Y, Xu W, Wang XL, Zhao WH, Wu JQ. 2010. The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: Evidence from 6501 subjects. Lung Cancer 70:247-252.
9. Deng Q, Sheng L, Su D, Zhang L, Liu P, Lu K, Ma S. 2011. Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Med Oncol 28:667-672.
10. Eom SY, Zhang YW, Kim SH, Choe KH, Lee KY, Park JD, Hong YC, Kim YD, Kang JW, Kim H. 2009. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control 20:137-145.
11. García-Suástegui WA, Huerta-Chagoya A, Carrasco-Colín KL, Pratt MM, John K, Petrosyan P, Rubio J, Poirier MC, Gonsebatt ME. 2011. Seasonal variations in the levels of PAH-DNA adducts in young adults living in Mexico City. Mutagenesis 26:385-391.
12. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case L. 2001. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22:917-922.
13. Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, Benhamou S, Bouchardy C, Lan Q, Spitz MR, Wichmann HE, LeMarchand L, Vineis P, Matullo G, Kiyohara C, Zhang ZF, Pezeshki B, Harris C, Mechanic L, Seow A, Ng DP, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Caporaso N, Chen C, Duell EJ, Goodman G, Field JK, Houlston RS, Hong YC, Landi MT, Lazarus P, Muscat J, McLaughlin J, Schwartz AG, Shen H, Stucker I, Tajima K, Matsuo K, Thun M, Yang P, Wiencke J, Andrew AS, Monnier S, Boffetta P, Brennan P. 2008. International lung cancer consortium: Pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 17:3081-3089.
14. Ihsan R, Chauhan PS, Mishra AK, Yadav DS, Kaushal M, Sharma JD, Zomawia E, Verma Y, Kapur S, Saxena S. 2011. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer. PLoS One 6:e29431.
15. International Agency for Research on Cancer. 2012. A review of human carcinogens: Personal habits and indoor combustions, IARC Monog Eval Carcinog Risks Chem Hum 100(Pt E):1-538.
16. Ketelslegers HB, Gottschalk RW, Knaapen AM, van Schooten FJ, Vlietinck RF, Kleinjans JC, van Delft JH. 2006. Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol Biomarkers Prev 15:624-629.
17. Knaapen AM, Ketelslegers HB, Gottschalk RW, Janssen RG, Paulussen AD, Smeets HJ, Godschalk RW, Van Schooten FJ, Kleinjans JC, Van Delft JH. 2004. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension. Clin Chem 50:1664-1668.
18. Langie SA, Knaapen AM, Houben JM, van Kempen FC, de Hoon JP, Gottschalk R, Godschalk RW, van Schooten FJ. 2007. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress. Toxicol Lett 168:302-309.
19. Li X, Hu Z, Qu X, Zhu J, Li L, Ring BZ, Su L. 2011. Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: A comprehensive meta-analysis. PLoS One 6:e14749.
20. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, Piazza A, Vineis P. 2001. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92:562-567.
21. Merlo F, Bolognesi C, Peluso M, Valerio F, Abbondandolo A, Puntoni R. 1997. Airborne levels of polycyclic aromatic hydrocarbons: 32P-postlabeling DNA adducts and micronuclei in white blood cells from traffic police workers and urban residents. J Environ Pathol Toxicol Oncol 16:157-162.
22. Munnia A, Saletta F, Allione A, Piro S, Confortini M, Matullo G, Peluso M. 2007. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies. Mutagenesis 22:381-385.
23. Palli D, Masala G, Peluso M, Gaspari L, Krogh V, Munnia A, Panico S, Saieva C, Tumino R, Vineis P, Garte S. 2004. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: A study on 634 subjects. Carcinogenesis 25:577-584.
24. Park JH, Mangal D, Tacka KA, Quinn AM, Harvey RG, Blair IA, Penning TM. 2008. Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells. Proc Natl Acad Sci USA 105:6846-6851.
25. Peluso M, Castegnaro M, Malaveille C, Talaska G, Vineis P, Kadlubar F, Bartsch H. 1990. 32P-postlabelling analysis of DNA adducted with urinary mutagens from smokers of black tobacco. Carcinogenesis 11:1307-1311.
26. Peluso M, Amasio E, Bonassi S, Munnia A, Altrupa F, Parodi S. 1997. Detection of DNA adducts in human nasal mucosa tissue by 32P-postlabeling analysis. Carcinogenesis 18:339-344.
27. Peluso M, Neri M, Margarino G, Mereu C, Munnia A, Ceppi M, Buratti M, Felletti R, Stea F, Quaglia R, Puntoni R, Taioli E, Garte S, Bonassi S. 2004. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms. Carcinogenesis 25:2459-2465.
28. Peluso M, Srivatanakul P, Munnia A, Jedpiyawongse A, Meunier A, Sangrajrang S, Piro S, Ceppi M, Boffetta P. 2008. DNA adduct formation among workers in a Thai industrial estate and nearby residents. Sci Total Environ 389:283-288.
29. Peluso M, Munnia A, Piro S, Armillis A, Ceppi M, Matullo G, Puntoni R. 2010a. Smoking, DNA adducts and number of risk DNA repair alleles in lung cancer cases, in subjects with benign lung diseases and in controls. J Nucleic Acids 2010:386798.
30. Peluso M, Srivatanakul P, Munnia A, Jedpiyawongse A, Ceppi M, Sangrajrang S, Piro S, Boffetta P. 2010b. Malondialdehyde-deoxyguanosine adducts among workers of a Thai industrial estate and nearby residents. Environ Health Perspect 118:55-59.
31. Peluso M, Bollati V, Munnia A, Srivatanakul P, Jedpiyawongse A, Sangrajrang S, Piro S, Ceppi M, Bertazzi PA, Boffetta P, Baccarelli AA. 2012a. Global and gene specific methylation in workers of Map Ta Phut industrial estate and nearby residents. Int J Epidemiol 41:1753-1760.
32. Peluso M, Munnia A, Piro S, Jedpiyawongse A, Sangrajrang S, Giese RW, Ceppi M, Boffetta P, Srivatanakul P. 2012b. Fruit and vegetable and fried food consumption and 3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1, 2-α] purin-10(3H)-one deoxyguanosine adduct formation. Free Radic Res 46:85-92.
33. Peluso M, Munnia A, Ceppi M, Giese RW, Godschalk RWL, Catelan D, Rusconi F, Godschalk RW, Biggeri A. 2013a. Malondialdehyde-deoxyguanosine and aromatic DNA adducts among schoolchildren living near the Sarroch industrial estate. Mutagenesis 28:315-321.
34. Peluso M, Srivatanakul P, Jedpiyawongse A, Sangrajrang S, Munnia A, Piro S, Ceppi M, Boffetta P, Godschalk RW, van Schooten FJ. 2013a. Aromatic DNA adducts and number of lung cancer risk alleles in Map-Ta-Phut Industrial Estate workers and nearby residents. Mutagenesis 28:57-63.
35. Phillips DH, Venitt S. 2012. DNA and protein adducts in human tissues resulting from exposure to tobacco smoke. Int J Cancer 131:2733-2753.
36. Pliarchopoulou K, Voutsinas G, Papaxoinis G, Florou K, Skondra M, Kostaki K, Roussou P, Syrigos K, Pectasides D. 2012. Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers. Oncol Lett 3:1301-1306.
37. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P. 2004. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25:2433-2441.
38. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, Romkes M, Schneider J, Seow A, Shields PG, Sobti RC, Sørensen M, Spinola M, Spitz MR, Strange RC, Stücker I, Sugimura H, To-Figueras J, Tokudome S, Yang P, Yuan JM, Warholm M, Taioli E. 2006. Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review. Am J Epidemiol 164:1027-1042.
39. Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, Taylor PR, Albanes D. 2000. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 60:6381-6383.
40. Reed GA, Ryan MJ. 1990. Peroxyl radical-dependent epoxidation of cyclopenteno[c, d]pyrene. Carcinogenesis 11:1825-1829.
41. Rotunno M, Yu K, Lubin HJ, Consonni D, Pesatori CA, Goldstein MA, Goldin LR, Wacholder S, Welch R, Burdette L, Chanock SJ, Bertazzi PA, Tucker MA, Caporaso NE, Chatterjee N, Bergen AW, Landi MT. 2012. Phase I metabolic genes and risk of lung cancer: Multiple polymorphisms and mRNA expression. PLoS One 4:e5652.
42. San Jose C, Cabanillas A, Benitez J, Carrillo JA, Jimenez M, Gervasini G. 2010. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: A case control study. BMC Cancer 10:463.
43. Schlager JJ, Powis G. 1990. Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol. Int J Cancer 45:403-409.
44. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. 1996. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 226:561-565.
45. Sims P, Grover PL, Swaisland A, Pal K, Hewer A. 1974. Metabolic activation of benzo-(a)pyrene proceeds by a diol-epoxide. Nature 252:326-328.
46. Smith LE, Denissenko MF, Bennet WP, Li H, Amin S, Tang M., Pfeifer GP. 2000. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst 92:803-811.
47. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. 2009. The many functions of APE1/Ref-1: Not only a DNA repair enzyme. Antioxid Redox Signal 11:601-620.
48. Tokuhata GK, Lilienfeld AM. 1963. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 30:289-312.
49. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D. 1997. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br J Cancer 75:69-75.
50. Van Schooten FJ, Boots AW, Knaapen AM, Godschalk RW, Maas LM, Borm, PJ, Drent M, Jacobs JA 2004. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev 13:828-833.
51. Veglia F, Loft S, Matullo G, Peluso M, Munnia A, Perera F, Phillips DH, Tang D, Autrup H, Raaschou-Nielsen O, Tjønneland A, Vineis P; Genair-EPIC Investigators. 2008. DNA adducts and cancer risk in prospective studies: A pooled analysis and a meta-analysis. Carcinogenesis 29:932-936.
52. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, Yang IA, Bowman RV, Fong KM. 2010. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J 35:152-159.
53. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. 2006. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27:560-567.
54. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A. 2008. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29:1164-1169.